Contact
Please use this form to send email to PR contact of this press release:
IntelGenx Announces Resubmission of RIZAPORT® New Drug Application
TO:
Please use this form to send email to PR contact of this press release:
IntelGenx Announces Resubmission of RIZAPORT® New Drug Application
TO: